Baker Bros. Advisors Lp Insider Profile
235 Followers
Baker Bros. Advisors Lp, Director at Madrigal Pharmaceuticals, holds 2.24M shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 20.42M shares in Kodiak Sciences (Ticker: KOD), holds 4.37M shares in Celcuity (Ticker: CELC). Most recently, Baker Bros. Advisors Lp Bought ― shares of Madrigal Pharmaceuticals on Nov 06, 2026 for an estimated value of $35.02M.
Baker Bros. Advisors Lp's Trading History
| KODKodiak Sciences | Nov 06, 2026 | Director, Ten Percent Owner | Informative Buy | 24.34M | $2.27B | |
| MDGLMadrigal Pharmaceuticals | Nov 06, 2026 | Director | Informative Buy | 35.02M | $959.24M | |
| CELCCelcuity | Jul 16, 2026 | Former 10% owner | Informative Sell | 317.75M | $281.48M | |
| INCYIncyte | Jul 02, 2026 | Director, Ten Percent Owner | Uninformative Buy | ― | $3.48B | |
| ONCBeOne Medicines | Jun 15, 2026 | Director | Uninformative Buy | ― | $3.74B | |
| DNLIDenali Therapeutics | Jun 05, 2026 | Director | Uninformative Buy | ― | $64.14M | |
| ACADACADIA Pharmaceuticals | Jun 02, 2026 | Director, Ten Percent Owner | Uninformative Buy | ― | $742.32M | |
| KNSAKiniksa Pharmaceuticals | Jun 02, 2026 | Director | Uninformative Buy | ― | $267.27M | |
| BCYCBicycle Therapeutics | Jan 06, 2026 | Director, Ten Percent Owner | Uninformative Buy | ― | $33.76M | |
| KYMRKymera Therapeutics | Dec 11, 2025 | Director, Ten Percent Owner | Informative Buy | 172.50M | $1.01B | |
| TRDAEntrada Therapeutics Inc | Nov 24, 2025 | Ten Percent Owner | Informative Buy | 261.68K | $23.88M | |
| KALAKALA BIO | Oct 02, 2025 | Former 10% owner | Informative Sell | 1.05M | $58.65K | |
| VTVTvTv Therapeutics | Sep 05, 2025 | Director | Uninformative Buy | ― | $2.68M | |
| IGMSIGM Biosciences | Aug 18, 2025 | ― | Uninformative Sell | ― | $0.00 | |
| IMCRImmunocore Holdings | Mar 19, 2025 | Director | Informative Buy | 23.99M | $64.19M | |
| BLCMBellicum Pharmaceuticals | Nov 24, 2023 | ― | Uninformative Buy | ― | $160.49K | |
| BCELAtreca | Oct 23, 2023 | ― | Informative Sell | 109.90K | $267.40K | |
| NGNENeurogene | Oct 10, 2023 | Director, Former 10% Owner | Uninformative Buy | ― | $10.86M | |
| SGENSeagen | Jun 02, 2023 | ― | Uninformative Buy | ― | $9.84B | |
| DBVTDBV Technologies SA - American | Jun 13, 2022 | Director | Uninformative Buy | ― | $321.53M | |
| TCRXTScan Therapeutics | May 12, 2022 | Director | Informative Buy | 2.56M | $404.57K | |
| TLISTalis Biomedical | Nov 19, 2021 | ― | Informative Buy | 218.00K | $21.66M | |
| PRLDPrelude Therapeutics | Jan 29, 2021 | Director, Ten Percent Owner | Uninformative Buy | 133.33K | $31.92M | |
| ALXNAlexion Pharmaceuticals | May 18, 2020 | ― | Uninformative Buy | ― | $1.47B | |
| GHDXGenomic Health | Oct 03, 2019 | ― | Uninformative Buy | 124.47K | $484.81M | |
| ACGNAceragen | Jul 03, 2019 | ― | Uninformative Buy | 15.47K | $1.65M | |
| HOOKHookipa Pharma | Apr 23, 2019 | ― | Informative Buy | 12.50M | $943.84K | |
| NVTAQInvitae | Mar 29, 2018 | ― | Informative Buy | 5.00M | $83.09K | |
| MRTXMirati Therapeutics | Nov 13, 2017 | ― | Informative Buy | 2.20M | $2.13M | |
| BCRXBioCryst | Aug 16, 2016 | Ten Percent Owner | Informative Sell | 20.25M | $114.63M | |
| XOMAXOMA Royalty Corporation | Jul 23, 2015 | ― | Informative Sell | 11.99M | $3.64M | |
| GEVASynageva | ― | ― | ― | ― | ||
| REPLReplimune Group | ― | Director, Ten Percent Owner | ― | ― | ||
| ZYMEZymeworks | ― | Director | ― | ― | ||
| SYRESpyre Therapeutics | ― | Director | ― | ― |
You May Also Like
Baker Bros. Advisors Lp insider profile FAQ
What is the percentage of profitable transactions made by Baker Bros. Advisors Lp?
The percentage of profitable transactions made by Baker Bros. Advisors Lp is 56%.
What is the average return per transaction made by Baker Bros. Advisors Lp?
The average return per transaction made by Baker Bros. Advisors Lp is 29.90%.
What stocks does Baker Bros. Advisors Lp hold?
Baker Bros. Advisors Lp holds: MDGL, ALXN, BCRX, ACGN, DBVT, BLCM, VTVT, ONC, SYRE, ZYME, KALA, CELC, DNLI, KNSA, REPL, KOD, HOOK, BCYC, BCEL, IGMS, KYMR, PRLD, IMCR, TLIS, TCRX, TRDA, MRTX, NGNE, NVTAQ, ACAD, XOMA, GHDX, INCY, SGEN, GEVA stocks.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp’s latest transaction was an Informative Buy of $35.02M.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in Madrigal Pharmaceuticals?
Baker Bros. Advisors Lp's role in Madrigal Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
